Metropolis Healthcare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Metropolis Healthcare Limited generated cash of $2,640,699,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,811,985,000 last year. Net change in cash is therefore -$62,149,000.
Cash Flow
| 2016 | 914.16M | 963.61M | -1.73B |
|---|---|---|---|
| 2018 | 1.03B | 18.82M | -873.03M |
| 2020 | 2.15B | -1.04B | -553.23M |
| 2021 | 2.49B | 617.01M | -326.90M |
| 2023 | 2.47B | 467.94M | -2.92B |
| 2024 | 2.64B | -894.11M | -1.81B |
METROPOLIS.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 688.33M | 659.80M | 1.07B | 513.71M | 255.09M | 128.91M |
Operating activities | ||||||
Net income | 1.27B | 1.87B | 2.44B | 1.68B | 1.60B | 1.27B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 944.67M | 892.15M | 459.44M | 392.67M | 190.17M | 166.41M |
Stock-based compensation expense | 14.16M | 2.85M | 77.87M | 7.23M | 16.6M | 0 |
| Deferred income tax benefit | 14.16M | 2.85M | 77.87M | 7.23M | 16.6M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -123.69M | 158.26M | -138.94M | -242.01M | -209.38M | -115.59M |
Inventories | 58.97M | 65.15M | -161.47M | 17.01M | -54.05M | 3.54M |
Accounts payable | 57.00M | -53.12M | 234.41M | 316.32M | -15.72M | 49.76M |
Cash generated by operating activities | 2.64B | 2.47B | 2.49B | 2.15B | 1.03B | 914.16M |
Investing activities | ||||||
Purchases Of Investments | -1.57B | -2.55B | 53.94M | -852.91M | -4.31B | -1.00B |
Investments In Property Plant And Equipment | -637.61M | -526.33M | -282.72M | -362.06M | -198.95M | -167.19M |
Acquisitions Net | -6.5M | 66.5M | -53.94M | -123.79M | -118.11M | -17.37M |
Cash generated by investing activities | -894.11M | 467.94M | 617.01M | -1.04B | 18.82M | 963.61M |
Financing activities | ||||||
Common Stock Issued | 34K | 1.83M | 343.17M | 318.92M | 0 | 0 |
Payments for dividends | -204.96M | -409.68M | -408.93M | -483.94M | -527.48M | -828.94M |
Repurchases of common stock | 0 | 0 | -252.56M | 0 | -1.10M | -603.2M |
Repayments of term debt | -790.52M | -1.78B | -351K | -177.44M | -2.69M | -56.67M |
Cash used in financing activities | -1.81B | -2.92B | -326.90M | -553.23M | -873.03M | -1.73B |
Net Change In Cash | -62.14M | 28.52M | 2.79B | 558.03M | 179.59M | 139.41M |
Cash at end of period | 626.18M | 688.33M | 3.86B | 1.07B | 434.68M | 268.32M |
| Data source | Data source | Data source | Data source | Data source | Data source |